Cargando…
Sphingolipid Metabolism and Obesity-Induced Inflammation
Obesity is a metabolic disorder developed by overnutrition and a major cause for insulin resistance and cardiovascular events. Since adipose tissue is one of the major sites for the synthesis and secretion of cytokines, enlarged adipose tissue in obese condition alters inflammatory state leading to...
Autores principales: | Kang, Se-Chan, Kim, Bo-Rahm, Lee, Su-Yeon, Park, Tae-Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671289/ https://www.ncbi.nlm.nih.gov/pubmed/23761785 http://dx.doi.org/10.3389/fendo.2013.00067 |
Ejemplares similares
-
Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
por: Blachnio-Zabielska, Agnieszka, et al.
Publicado: (2022) -
Editorial: Sphingolipid metabolism dysfunction in cancer
por: El Ridi, Rashika, et al.
Publicado: (2023) -
Sphingolipid metabolism in brain insulin resistance and neurological diseases
por: Mei, Meng, et al.
Publicado: (2023) -
Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology
por: Tan-Chen, Sophie, et al.
Publicado: (2020) -
Dysregulated sphingolipid metabolism and autophagy in granulosa cells of women with endometriosis
por: Turathum, Bongkoch, et al.
Publicado: (2022)